Tyrosine Kinase Inhibitors in Paediatric Leukaemia Show Distinct Early Adverse Signals
A pharmacovigilance analysis of FAERS data identified distinct developmental and organ-specific adverse event signals alongside early reporting patterns for tyrosine ...

